In8bio Inc Stock Performance
| INAB Stock | USD 1.93 0.00 0.00% |
On a scale of 0 to 100, In8bio holds a performance score of 7. The company owns a Beta (Systematic Risk) of 0.12, which attests to not very significant fluctuations relative to the market. As returns on the market increase, In8bio's returns are expected to increase less than the market. However, during the bear market, the loss of holding In8bio is expected to be smaller as well. Please check In8bio's information ratio, treynor ratio, and the relationship between the downside deviation and total risk alpha , to make a quick decision on whether In8bio's current price history will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in In8bio Inc are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating basic indicators, In8bio sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 1:30 | Last Split Date 2025-06-06 |
1 | Can IN8bio Inc. stock hit analyst price targets - Buy Signal Weekly Setup with ROI Potential - newser.com | 11/11/2025 |
2 | Can IN8bio Inc. stock reach 200 price target - Rate Hike AI Powered Buy and Sell Recommendations - newser.com | 11/17/2025 |
3 | Is IN8bio Inc. stock cheap at current valuation - 2025 Key Lessons Daily Volume Surge Trade Alerts - newser.com | 11/20/2025 |
4 | IN8bio Inc. Stock Price Live Quotes Charts NASDAQ - StocksToTrade | 12/02/2025 |
5 | Street Watch Will IN8bio Inc. stock attract ESG investors - Quarterly Profit Report AI Enhanced Trading Alerts - | 12/18/2025 |
6 | Acquisition by Fairbairn Emily of 724637 shares of In8bio at 1.38 subject to Rule 16b-3 | 12/22/2025 |
7 | Acquisition by Kate Rochlin of 7247 shares of In8bio at 1.38 subject to Rule 16b-3 | 12/26/2025 |
8 | IN8bio Presents Updated Phase III Data Demonstrating Meaningful and Durable Survival Improvements in Newly Diagnosed Glioblastoma | 01/12/2026 |
9 | IN8bio to Present at Upcoming Investor and Scientific Conferences in February | 02/03/2026 |
| Begin Period Cash Flow | 21.5 M | |
| Total Cashflows From Investing Activities | -187 K |
In8bio Relative Risk vs. Return Landscape
If you would invest 155.00 in In8bio Inc on November 7, 2025 and sell it today you would earn a total of 44.00 from holding In8bio Inc or generate 28.39% return on investment over 90 days. In8bio Inc is currently generating 0.6573% in daily expected returns and assumes 7.192% risk (volatility on return distribution) over the 90 days horizon. In different words, 64% of stocks are less volatile than In8bio, and 87% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
In8bio Target Price Odds to finish over Current Price
The tendency of In8bio Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.93 | 90 days | 1.93 | about 50.0 |
Based on a normal probability distribution, the odds of In8bio to move above the current price in 90 days from now is about 50.0 (This In8bio Inc probability density function shows the probability of In8bio Stock to fall within a particular range of prices over 90 days) .
In8bio Price Density |
| Price |
Predictive Modules for In8bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as In8bio Inc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.In8bio Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. In8bio is not an exception. The market had few large corrections towards the In8bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold In8bio Inc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of In8bio within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.21 | |
β | Beta against Dow Jones | 0.12 | |
σ | Overall volatility | 0.32 | |
Ir | Information ratio | 0.02 |
In8bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of In8bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for In8bio Inc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| In8bio Inc is way too risky over 90 days horizon | |
| In8bio Inc may become a speculative penny stock | |
| In8bio Inc appears to be risky and price may revert if volatility continues | |
| In8bio Inc has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (30.44 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| In8bio Inc currently holds about 25.74 M in cash with (24.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.37. | |
| In8bio Inc has a frail financial position based on the latest SEC disclosures | |
| Roughly 23.0% of the company shares are held by company insiders | |
| Latest headline from finance.yahoo.com: IN8bio to Present at Upcoming Investor and Scientific Conferences in February |
In8bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of In8bio Stock often depends not only on the future outlook of the current and potential In8bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. In8bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 53.5 M | |
| Cash And Short Term Investments | 11.1 M |
In8bio Fundamentals Growth
In8bio Stock prices reflect investors' perceptions of the future prospects and financial health of In8bio, and In8bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on In8bio Stock performance.
| Return On Equity | -1.9 | ||||
| Return On Asset | -0.8 | ||||
| Current Valuation | 11.41 M | ||||
| Shares Outstanding | 9.77 M | ||||
| Price To Book | 1.47 X | ||||
| EBITDA | (26.94 M) | ||||
| Net Income | (30.44 M) | ||||
| Cash And Equivalents | 25.74 M | ||||
| Cash Per Share | 1.37 X | ||||
| Total Debt | 5.03 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 9.08 X | ||||
| Book Value Per Share | 2.87 X | ||||
| Cash Flow From Operations | (24.15 M) | ||||
| Earnings Per Share | (5.26) X | ||||
| Market Capitalization | 19.43 M | ||||
| Total Asset | 20.94 M | ||||
| Retained Earnings | (121.66 M) | ||||
| Working Capital | 9.49 M | ||||
About In8bio Performance
By analyzing In8bio's fundamental ratios, stakeholders can gain valuable insights into In8bio's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if In8bio has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if In8bio has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 51.33 | 45.62 | |
| Return On Tangible Assets | (1.31) | (1.37) | |
| Return On Capital Employed | (1.53) | (1.61) | |
| Return On Assets | (1.31) | (1.37) | |
| Return On Equity | (2.42) | (2.30) |
Things to note about In8bio Inc performance evaluation
Checking the ongoing alerts about In8bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for In8bio Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| In8bio Inc is way too risky over 90 days horizon | |
| In8bio Inc may become a speculative penny stock | |
| In8bio Inc appears to be risky and price may revert if volatility continues | |
| In8bio Inc has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (30.44 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| In8bio Inc currently holds about 25.74 M in cash with (24.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.37. | |
| In8bio Inc has a frail financial position based on the latest SEC disclosures | |
| Roughly 23.0% of the company shares are held by company insiders | |
| Latest headline from finance.yahoo.com: IN8bio to Present at Upcoming Investor and Scientific Conferences in February |
- Analyzing In8bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether In8bio's stock is overvalued or undervalued compared to its peers.
- Examining In8bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating In8bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of In8bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of In8bio's stock. These opinions can provide insight into In8bio's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for In8bio Stock analysis
When running In8bio's price analysis, check to measure In8bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy In8bio is operating at the current time. Most of In8bio's value examination focuses on studying past and present price action to predict the probability of In8bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move In8bio's price. Additionally, you may evaluate how the addition of In8bio to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities |